BioTuesdays

Category - Developments

Ortho Regenerative Technologies

Ortho RTi presents 4 studies at ORS meeting

Ortho Regenerative Technologies presented results of four key scientific studies at the 2017 Orthopaedic Research Society annual meeting in San Diego, validating its product’s ability to improve the repair of...

3D Signatures

3DS TeloView identifies and stages AD patients

3D Signatures (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) announced that clinical study results confirm that based on a swab from the inside of a patient’s cheek, its TeloView software platform has the ability to identify patients...

3D Signatures

3DS makes final patent payment

3D Signatures (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) recently made the final payment to CancerCare Manitoba (CCMB) for the purchase of intellectual property. All patents were assigned from CCMB to 3DS in June 2014. Quarterly...

Jaguar Animal Health

Jaguar seeks MUMS designation for EID in dogs

Jaguar Animal Health (NASDAQ:JAGX) has submitted a formal request to the FDA’s Center for Veterinary Medicine for a determination whether Canalevia qualifies under the requirements of the Minor Use and Minor Species...

BioTime

BioTime opens U.S. sites in dry AMD trial

BioTime (NYSE MKT:BTX) is expanding its ongoing Phase 1/2a clinical trial for OpRegen in the advanced dry form of AMD by naming the first two sites that will treat patients in the U.S. “The addition of U.S. clinical...

Histogenics

Histogenics cartilage data published

Histogenics (NASDAQ:HSGX) announced the online peer-reviewed publication in the Journal of Orthopaedic Research that analyzes mechanical properties of tissue engineered cartilage based on work done as part of a...